Abstract
Radiofrequency ablation and percutaneous ethanol injection are used as treatments for hepatocellular carcinoma due to their ability to induce tumour necrosis (death). However, there is limited randomised controlled trial (RCT) evidence regarding the relative efficacy of these treatments in people with small liver tumours.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
